BSE Live
Jan 01, 16:00Prev. Close
0.75
Open Price
0.84
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Key Financial Ratios of Remedium Lifecare (in Rs. Cr.) | Mar 25 | |
| Per Share Ratios | ||
| Basic EPS (Rs.) | 0.05 | |
| Diluted EPS (Rs.) | 0.05 | |
| Cash EPS (Rs.) | 0.05 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 1.09 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 1.09 | |
| Revenue from Operations/Share (Rs.) | 10.05 | |
| PBDIT/Share (Rs.) | 0.24 | |
| PBIT/Share (Rs.) | 0.24 | |
| PBT/Share (Rs.) | 0.11 | |
| Net Profit/Share (Rs.) | 0.05 | |
| NP After MI And SOA / Share (Rs.) | 0.05 | |
| Profitability Ratios | ||
| PBDIT Margin (%) | 2.39 | |
| PBIT Margin (%) | 2.38 | |
| PBT Margin (%) | 1.08 | |
| Net Profit Margin (%) | 0.52 | |
| NP After MI And SOA Margin (%) | 0.52 | |
| Return on Networth/Equity (%) | 4.85 | |
| Return on Capital Employed (%) | 22.03 | |
| Return on Assets (%) | 0.12 | |
| Total Debt/Equity (X) | 26.01 | |
| Asset Turnover Ratio (%) | 0.00 | |
| Liquidity Ratios | ||
| Current Ratio (X) | 1.03 | |
| Quick Ratio (X) | 0.87 | |
| Inventory Turnover Ratio (X) | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | |
| Coverage Ratios | ||
| Interest Coverage Ratios (%) | 1.84 | |
| Interest Coverage Ratios (Post Tax) (%) | 1.84 | |
| Valuation Ratios | ||
| Enterprise Value (Cr.) | 1,213.35 | |
| EV/Net Operating Revenue (X) | 2.99 | |
| EV/EBITDA (X) | 124.94 | |
| MarketCap/Net Operating Revenue (X) | 0.18 | |
| Retention Ratios (%) | 0.00 | |
| Price/BV (X) | 1.67 | |
| Price/Net Operating Revenue | 0.18 | |
| Earnings Yield | 0.03 |
27.11.2025
Remedium Lifeca Standalone September 2025 Net Sales at Rs 8.58 crore, down 65.8% Y-o-Y
05.08.2025
Remedium Lifeca Standalone June 2025 Net Sales at Rs 18.37 crore, down 76.35% Y-o-Y
24.06.2025
Remedium Lifeca Standalone March 2025 Net Sales at Rs 81.57 crore, down 94.21% Y-o-Y
26.11.2024
Remedium Lifeca Standalone September 2024 Net Sales at Rs 25.08 crore, down 94.65% Y-o-Y
27.11.2025
Remedium Lifeca Standalone September 2025 Net Sales at Rs 8.58 crore, down 65.8% Y-o-Y
05.08.2025
Remedium Lifeca Standalone June 2025 Net Sales at Rs 18.37 crore, down 76.35% Y-o-Y
24.06.2025
Remedium Lifeca Standalone March 2025 Net Sales at Rs 81.57 crore, down 94.21% Y-o-Y
26.11.2024
Remedium Lifeca Standalone September 2024 Net Sales at Rs 25.08 crore, down 94.65% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017